IOL Chemicals and Pharmaceuticals Limited — Others, 22-08-2025: Shareholders meeting

IOL Chemicals and Pharmaceuticals Limited held its 38th Annual General Meeting via video conferencing, where all proposed resolutions were passed with the necessary majority. Shareholders adopted the standalone and consolidated audited financial statements for the financial year ended March 31, 2025. Key approvals included the re-appointment of Mr. Abhiraj Gupta as Director and Mr. Vikas Gupta as Joint Managing Director. The appointment of M/s B.K. Gupta & Associates as Secretarial Auditor and the ratification of the Cost Auditor’s remuneration were also approved. These decisions are vital for the company's governance and continued operations, reflecting shareholder confidence.